INTEREST IN THE ADDITION OF AZATHIOPRINE (AZA) TO THE SWITCH OF ANTI-TNF IN IBD PATIENTS IN CLINICAL RELAPSE WITH UNDETECTABLE ANTI-TNF TROUGH LEVELS AND ANTI-DRUG ANTIBODIES: A PROSPECTIVE RANDOMIZED TRIAL

Xavier Roblin  1     Stéphane Paul  2     Gilles Boschetti  3     Jean Marc Phelip  4     Emilie Del Tedesco  5     Stéphane Nancey  6     Nicolas Williet  7     Bernard Flourie    
1 University of St. Etienne Dept. de Gastroenterologie,Saint Etienne,France
2 CHU Saint Etienne,Saint-Priest En Jarez,France
3 Hospital Lyon-Sud Dept. of Gastroenterology,Pierre-Benite,France
4 UNIVERSITY, Saint etienne, France,Saint Etienne,France
5 Université saint etienne,Saint etienne,France
6 Lyon university,Pierre Benite,France
7 Chu S

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing